Treace Medical Concepts, Inc. (NASDAQ: TMCI) Q3 2024 Earnings Call Transcript November 5, 2024 Treace Medical Concepts, Inc. beats earnings expectations. Reported EPS is $-0.25, expectations were ...

One of the key variables thought to be most likely to increase demand for the market under study is the rising prevalence of ...

The medical device sector is evolving, driven by rising demand for precision technology in diagnostics. Therefore, it could ...

In a report released on November 1, David Toung from Argus Research maintained a Buy rating on Stryker (SYK – Research Report). The ...

The first cases with Stryker's Mako Spine robot have been completed ahead of its anticipated launch, Vice President of Investor Relations Jason Beach said in an ...

Treatments that address both complex trauma and disrupted attachment can be effective. Not all complex trauma treatment ...

After hours: 1 November at 6:40 pm GMT-4 ...

The global neuroendoscopy devices market is on the cusp of significant expansion, projected to grow from USD 214.5 million in 2023 to USD 345 million by 2033, marking a compound annual growth rate ...

The global sales of foot and ankle devices are projected to reach an impressive USD 8,754.0 million by 2034, up from an estimated USD 4,934.5 million in 2024, representing a robust compound annual ...

The company engages in designing, manufacturing and marketing orthopedic reconstructive products; biologics, sports medicine, extremities and trauma products; spine, dental implants, bone healing ...